84 related articles for article (PubMed ID: 34980560)
1. Factors associated with early nonpersistence among patients experiencing side effects from a new medication.
Alefan Q; Yao S; Taylor JG; Lix LM; Eurich D; Choudhry N; Blackburn DF
J Am Pharm Assoc (2003); 2022; 62(3):717-726.e5. PubMed ID: 34980560
[TBL] [Abstract][Full Text] [Related]
2. Measuring the Influence of Side Effect Expectations, Beliefs, and Incident Side Effects on the Risk for Drug Discontinuation Among Individuals Starting New Medications, a Cross-sectional Study.
Blackburn DF; Yao S; Taylor JG; Alefan Q; Lix LM; Eurich DT; Choudhry NK
Patient Prefer Adherence; 2024; 18():979-989. PubMed ID: 38774475
[TBL] [Abstract][Full Text] [Related]
3. Medication persistence rates and factors associated with persistence in patients following stroke: a cohort study.
Lummis HL; Sketris IS; Gubitz GJ; Joffres MR; Flowerdew GJ
BMC Neurol; 2008 Jul; 8():25. PubMed ID: 18616796
[TBL] [Abstract][Full Text] [Related]
4. An algorithm to identify medication nonpersistence using electronic pharmacy databases.
Parker MM; Moffet HH; Adams A; Karter AJ
J Am Med Inform Assoc; 2015 Sep; 22(5):957-61. PubMed ID: 26078413
[TBL] [Abstract][Full Text] [Related]
5. The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs.
Lunghi C; Moisan J; Grégoire JP; Guénette L
Value Health; 2017 Jun; 20(6):728-735. PubMed ID: 28577689
[TBL] [Abstract][Full Text] [Related]
6. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal of antihypertensive drugs in older people.
Reeve E; Jordan V; Thompson W; Sawan M; Todd A; Gammie TM; Hopper I; Hilmer SN; Gnjidic D
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012572. PubMed ID: 32519776
[TBL] [Abstract][Full Text] [Related]
8. First-fill medication discontinuations and nonadherence to antihypertensive therapy: an observational study.
Evans CD; Eurich DT; Remillard AJ; Shevchuk YM; Blackburn D
Am J Hypertens; 2012 Feb; 25(2):195-203. PubMed ID: 22089108
[TBL] [Abstract][Full Text] [Related]
9. Importance of including early nonadherence in estimations of medication adherence.
Raebel MA; Carroll NM; Ellis JL; Schroeder EB; Bayliss EA
Ann Pharmacother; 2011 Sep; 45(9):1053-60. PubMed ID: 21852598
[TBL] [Abstract][Full Text] [Related]
10. Risk of discontinuation of risperidone after exposure to potentially interacting drugs: a nested case-control study in patients with schizophrenia.
Ishak KJ; Tan Y; Glass J; Luong D; Caro JJ
Clin Ther; 2008 Jul; 30(7):1251-63. PubMed ID: 18691984
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus.
Chao J; Nau DP; Aikens JE
Clin Ther; 2007 Jan; 29(1):177-80. PubMed ID: 17379058
[TBL] [Abstract][Full Text] [Related]
12. Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS Trial.
Fanaroff AC; Peterson ED; Kaltenbach LA; Cannon CP; Choudhry NK; Henry TD; Anstrom KJ; Cohen DJ; Fonseca E; Khan ND; Fonarow GC; Wang TY
JAMA Cardiol; 2020 May; 5(5):532-539. PubMed ID: 32129795
[TBL] [Abstract][Full Text] [Related]
13. Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease.
Böhm M; Schumacher H; Laufs U; Sleight P; Schmieder R; Unger T; Teo K; Yusuf S
Am Heart J; 2013 Aug; 166(2):306-314.e7. PubMed ID: 23895814
[TBL] [Abstract][Full Text] [Related]
14. Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan.
Hwang DK; Liu CJ; Pu CY; Chou YJ; Chou P
JAMA Ophthalmol; 2014 Dec; 132(12):1446-52. PubMed ID: 25211300
[TBL] [Abstract][Full Text] [Related]
15. Initial persistence with antihypertensive therapies is associated with depression treatment persistence, but not depression.
Schmittdiel JA; Dyer W; Uratsu C; Magid DJ; O'Connor PJ; Beck A; Butler M; Ho MP; Vazquez-Benitez G; Adams AS
J Clin Hypertens (Greenwich); 2014 Jun; 16(6):412-7. PubMed ID: 24716533
[TBL] [Abstract][Full Text] [Related]
16. Predictors of discontinuing overactive bladder medications.
Brubaker L; Fanning K; Goldberg EL; Benner JS; Trocio JN; Bavendam T; Jumadilova Z
BJU Int; 2010 May; 105(9):1283-90. PubMed ID: 19912189
[TBL] [Abstract][Full Text] [Related]
17. Self-reported barriers to medication use in older women: Findings from the Women's Health Initiative.
Marcum ZA; Vasan S; Tom S; Hart L; Wang Y; Shadyab AH; LaCroix AZ; Gray SL
J Am Pharm Assoc (2003); 2019; 59(6):842-847. PubMed ID: 31405806
[TBL] [Abstract][Full Text] [Related]
18. Warnings without guidance: patient responses to an FDA warning about ezetimibe.
Shrank WH; Choudhry NK; Tong A; Myers J; Fischer MA; Swanton K; Slezak J; Brennan TA; Liberman JN; Moffit S; Avorn J; Carpenter D
Med Care; 2012 Jun; 50(6):479-84. PubMed ID: 22581012
[TBL] [Abstract][Full Text] [Related]
19. New medication adherence scale versus pharmacy fill rates in seniors with hypertension.
Krousel-Wood M; Islam T; Webber LS; Re RN; Morisky DE; Muntner P
Am J Manag Care; 2009 Jan; 15(1):59-66. PubMed ID: 19146365
[TBL] [Abstract][Full Text] [Related]
20. Preliminary development of the Medication Nonpersistence Scale.
Athavale AS; Bentley JP; Banahan BF; McCaffrey DJ; Pace PF
J Am Pharm Assoc (2003); 2017; 57(3):389-394.e1. PubMed ID: 28279599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
